Gossamer Bio, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated June 6, 2024, details the results of the Annual Meeting of Stockholders for Gossamer Bio, Inc. (Nasdaq: GOSS). The filing covers corporate governance matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on voting outcomes and does not contain financial performance data.
Material Changes and Voting Results
The following matters were voted upon at the Annual Meeting:
- Election of Directors: Two Class II directors were re-elected for a three-year term expiring in 2027.
- Skye Drynan: 161,240,706 votes For; 933,528 Withheld; 28,757,285 Broker Non-Votes.
- John Quisel, Ph.D., J.D.: 161,260,707 votes For; 913,527 Withheld; 28,757,285 Broker Non-Votes.
- Ratification of Auditors: The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
- Votes: 189,741,141 For; 1,157,767 Against; 32,611 Abstain; 0 Broker Non-Votes.
- Executive Compensation (Say-on-Pay): The advisory approval of named executive officer compensation was approved.
- Votes: 115,985,182 For; 40,356,919 Against; 5,831,133 Abstain; 28,757,285 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of voting tallies.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Note the significant number of broker non-votes (28,757,285) on the director election and executive compensation proposals.
- Observe the substantial "Against" votes (40,356,919) on the executive compensation advisory proposal, indicating notable shareholder dissent on pay practices.
- Confirm the re-election of Skye Drynan and John Quisel to the Board of Directors.